Cargando...
Systematic review of fondaparinux for heparin‐induced thrombocytopenia: When there are no randomized controlled trials
BACKGROUND: Fondaparinux is commonly used for treatment of heparin‐induced thrombocytopenia (HIT) despite lack of approval for this indication. High quality randomized controlled trials of this agent are unlikely to be forthcoming. OBJECTIVES: The objective of this systematic review is to update the...
Guardado en:
| Publicado en: | Res Pract Thromb Haemost |
|---|---|
| Autores principales: | , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
John Wiley and Sons Inc.
2018
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6178656/ https://ncbi.nlm.nih.gov/pubmed/30349886 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/rth2.12145 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|